|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets: | ||||||||||
| Cash | ||||||||||
| Cash | ||||||||||
| Accounts receivable | ||||||||||
| Employee receivables | ||||||||||
| Inventory | ||||||||||
| Prepaid expenses | ||||||||||
| Due from related party | ||||||||||
| Deposots on Inventory | ||||||||||
| Total current assets | ||||||||||
| net of accumulated depreciation of $5,131 and $1,980, respectively | ||||||||||
| Deposits | ||||||||||
| Total other assets | ||||||||||
| Fixed assets, net of accumulated depreciation of $36,013 and $30,785, respectively | ||||||||||
| Deposits | ||||||||||
| Total assets | ||||||||||
| Liabilities and shareholders (deficit) | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable and accrued expenses | ||||||||||
| Accrued interest | ||||||||||
| Deferred revenue | ||||||||||
| Notes payable | ||||||||||
| Notes payable - related party | ||||||||||
| Convertible demand notes payable | ||||||||||
| Convertible notes payable, net of discounts of $157,441 and $61,842, respectively | ||||||||||
| Derivative liability | ||||||||||
| Total current liabilities | ||||||||||
| Shareholders (deficit) | ||||||||||
| Common stock; $0.001 par value; 121,212,122 shares authorized; 37,500,000 and 100 shares issued and outstanding at December 31, 2011 and 2010, respectively | ||||||||||
| Series B preferred stock; $0.01 par value; 100 shares authorized; shares 100 shares issued and outstanding as of June 30, 2014 and December 31, 2013, respectively | ||||||||||
| Common stock; $0.001 par value; 5,000,000,000 shares authorized; 2,782,583 and 335,994,983 shares authorized and issued at June 30, 2014 and December 31, 2013, respectively | ||||||||||
| Common shares sold and unissued, 5,405,000 and 3,655,000 at March 31, 2012 and December 31, 2011, respectively March 31, 2012 and December 31, 2011, respectively | ||||||||||
| Common stock authorized and unissued; 750,000 and 3,655,000 at September 30, 2012 and December 31, 2012, respectively | ||||||||||
| Common shares sold and unissued, 1,666 at March 31, 2014 and December 31, 2013, respectively | ||||||||||
| Additional paid-in capital | ||||||||||
| Other comprehensive (loss) | ||||||||||
| Common stock payable | ||||||||||
| Deferred compensation | ||||||||||
| Other comprehensive income (loss) | ||||||||||
| Accumlated (deficit) | ||||||||||
| Total shareholders' equity | ||||||||||
| Total shareholders (deficit) | ||||||||||
| Total liabilities and shareholders (deficit) | ||||||||||
Loading...
